血液管理市场－全球产业规模、份额、趋势、机会和预测，按产品、组件、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球血液管理市场规模为136.2亿美元，预计到2030年将以6.90%的复合年增长率增长至203.3亿美元。全球血液管理市场涵盖了从捐血者招募和采集到处理、检测、储存和输血等一系列流程和技术，旨在确保安全、充足和高效的血液供应，其中包括先进的患者血液管理策略。推动市场扩张的关键因素包括：需要输血的慢性疾病发生率不断上升、全球外科手术量不断增长以及老年人口不断增加，而老年人口本身也更容易患上需要输血的疾病。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球血液管理市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依产品分类（仪器、配件、试剂及试剂盒、软体）
  • 依成分（全血、红血球、血浆）
  • 按最终使用者（血库、医院、诊断诊所、病理实验室）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美血液管理市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲血液管理市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太血液管理市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲血液管理市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲血液管理市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球血液管理市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Haemonetics Corporation
• Fresenius SE & Co. KGaA
• Terumo Corporation
• Immucor, Inc.
• B Braun Melsungen AG
• bioMerieux Inc.
• Kaneka Corporation
• Bio-Rad Laboratories, Inc.
• Grifols, SA
• F. Hoffmann-La Roche Ltd.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Blood Management Market, valued at USD 13.62 Billion in 2024, is projected to experience a CAGR of 6.90% to reach USD 20.33 Billion by 2030. The global blood management market encompasses the comprehensive set of processes and technologies involved in ensuring a safe, adequate, and efficient blood supply from donor recruitment and collection to processing, testing, storage, and transfusion, including advanced patient blood management strategies. Key drivers supporting market expansion include the increasing incidence of chronic diseases requiring transfusions, a rising volume of surgical procedures worldwide, and the growing elderly population predisposed to conditions necessitating blood products.

Key Market Drivers

The rising prevalence of chronic diseases and blood disorders profoundly drives demand within the global blood management market. Conditions such as sickle cell disease, thalassemia, and various cancers necessitate frequent transfusions and specialized blood products for patient survival and improved quality of life. For example, according to Frontiers in Public Health, August 27, 2024, "Sickle cell disease: a comparative perspective on global and national initiatives," approximately 300,000 infants are born annually with Sickle Cell Disease globally, primarily in sub-Saharan Africa, India, and the Middle East, establishing a continuous requirement for blood components. This pervasive need creates an expanding base for the blood management sector.

Key Market Challenges

A critical challenge impeding the growth of the global blood management market stems from the consistent need to maintain a sufficient and safe blood supply. This challenge is exacerbated by evolving donor demographics and increasingly stringent regulatory requirements, directly impacting the ability of blood establishments to sustain robust donor recruitment and retention programs. The fluctuations in donor availability necessitate significant operational investments in outreach and educational initiatives, diverting resources that could otherwise be allocated to market expansion or technological advancements.

Key Market Trends

The shift towards personalized blood management strategies represents a significant evolution in patient care, moving beyond standardized transfusion protocols to tailored interventions based on individual patient needs. This approach focuses on optimizing a patient's own blood health, minimizing unnecessary transfusions, and thereby reducing associated risks such as infections and adverse reactions. For instance, according to an AABB review of current advances in 2024, treating iron deficiency anemia with intravenous iron significantly reduced postoperative red blood cell transfusions by 70%, improving patient outcomes. This trend influences the market by driving demand for advanced diagnostic tools to assess patient-specific factors like anemia and coagulation status, along with pharmacological alternatives to blood

Key Market Players

• Haemonetics Corporation
• Fresenius SE & Co. KGaA
• Terumo Corporation
• Immucor, Inc.
• B Braun Melsungen AG
• bioMerieux Inc.
• Kaneka Corporation
• Bio-Rad Laboratories, Inc.
• Grifols, S.A.
• F. Hoffmann-La Roche Ltd.

Report Scope:

In this report, the Global Blood Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Blood Management Market, By Product:

• Instruments
• Accessories
• Reagents & Kits
• Software

Blood Management Market, By Component:

• Whole Blood
• Red Blood Cells
• Plasma

Blood Management Market, By End User:

• Blood Banks
• Hospitals
• Diagnostic Clinics
• Pathology Labs

Blood Management Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Blood Management Market.

Available Customizations:

Global Blood Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Blood Management Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Instruments, Accessories, Reagents & Kits, Software)
  • 5.2.2. By Component (Whole Blood, Red Blood Cells, Plasma)
  • 5.2.3. By End User (Blood Banks, Hospitals, Diagnostic Clinics, Pathology Labs)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Blood Management Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Component
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Blood Management Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Component
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Blood Management Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Component
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Blood Management Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Component
      • 6.3.3.2.3. By End User

7. Europe Blood Management Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Component
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Blood Management Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Component
      • 7.3.1.2.3. By End User
  • 7.3.2. France Blood Management Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Component
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Blood Management Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Component
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Blood Management Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Component
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Blood Management Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Component
      • 7.3.5.2.3. By End User

8. Asia Pacific Blood Management Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Component
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Blood Management Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Component
      • 8.3.1.2.3. By End User
  • 8.3.2. India Blood Management Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Component
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Blood Management Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Component
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Blood Management Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Component
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Blood Management Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Component
      • 8.3.5.2.3. By End User

9. Middle East & Africa Blood Management Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Component
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Blood Management Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Component
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Blood Management Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Component
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Blood Management Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Component
      • 9.3.3.2.3. By End User

10. South America Blood Management Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Component
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Blood Management Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Component
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Blood Management Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Component
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Blood Management Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Component
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Blood Management Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Haemonetics Corporation
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Fresenius SE & Co. KGaA
• 15.3. Terumo Corporation
• 15.4. Immucor, Inc.
• 15.5. B Braun Melsungen AG
• 15.6. bioMerieux Inc.
• 15.7. Kaneka Corporation
• 15.8. Bio-Rad Laboratories, Inc.
• 15.9. Grifols, S.A.
• 15.10. F. Hoffmann-La Roche Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer